# Autophagy, a novel player in acetaminophen (APAP)-induced hepatotoxicity

## TL;DR

This study shows that autophagy helps protect the liver from acetaminophen overdose by reducing toxic effects linked to endoplasmic reticulum stress.

## Contribution

The study identifies autophagy as a novel protective mechanism in acetaminophen-induced liver injury.

## Key findings

- Liver injury from acetaminophen overdose is reduced when XBP1 is specifically ablated in liver cells.
- Enhanced autophagy is linked to modulation of CYP2E1 activity, which affects acetaminophen metabolism.
- Autophagy is revealed as a key player in protecting against acetaminophen toxicity.

## Abstract

Acetaminophen (APAP), a widely used analgesic drug, is safe at therapeutic doses, but can produce significant hepatotoxicity upon overdose. Emerging evidence suggested that endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) are key mechanisms in APAP-mediated hepatotoxicity. While ER stress-UPR and macroautophagy/autophagy appear to be independent cellular processes, we found a cross-linked mechanism in APAP liver injury. The specific ablation in liver parenchyma of XBP1 (X-box binding protein 1), a transcription factor mediating ER stress, mitigates APAP-induced liver injury. Interestingly, this mechanism is linked to enhanced autophagy which seems to be responsible for the modulation of the enzymatic activity of CYP2E1, which is involved in the metabolic conversion of APAP, and ultimately protects liver against APAP toxicity. Altogether, our study highlighted autophagy as a novel player in the pathophysiology of APAP-induced liver injury and opened new therapeutic avenues for its modulation in patients with drug overdose.